Literature DB >> 211512

Growth factors from murine sarcoma virus-transformed cells.

J E de Larco, G J Todaro.   

Abstract

Murine sarcoma virus-transformed mouse fibroblasts produce polypeptide growth factors and release them into serum-free medium. These factors stimulate cells to divide in monolayer cultures and also to form colonies that grow progressively soft agar. Three major peaks of activity are seen, with apparent molecular weights of 25,000, 12,000, and 7000. The sarcoma growth factors are heat-stable, trypsin-sensitive, and active in nanogram quantities when tested for growth stimulation of untransformed rat and mouse fibroblasts. All three molecular species are also capable of competing for membrane epidermal growth factor (EGF) receptors when tested with 125I-labeled EGF. They differ from mouse EGF, however, in their molecular weights, in their inability to react with anti-EGF antibodies, and in their ability to convert cells to anchorage independent (agar) growth. For the above reasons, we conclude that the sarcoma growth factors are a new class of polypeptide tropic factors that confer on fibroblasts in vitro properties associated with the transformed phenotype.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 211512      PMCID: PMC392918          DOI: 10.1073/pnas.75.8.4001

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Glutamine metabolism by animal cells growing in a synthetic medium.

Authors:  P A KITOS; R SINCLAIR; C WAYMOUTH
Journal:  Exp Cell Res       Date:  1962-08       Impact factor: 3.905

2.  Mouse pituitary tumor mRNA directed cell-free synthesis of polypeptides that are cross-reactive with adrenocorticotropic hormone antiserum.

Authors:  R E Jones; P Pulkrabek; D Grunberger
Journal:  Biochem Biophys Res Commun       Date:  1977-02-21       Impact factor: 3.575

3.  MSA and EGF receptors on sarcoma virus transformed cells and human fibrosarcoma cells in culture.

Authors:  G J Todaro; J E De Larco; S P Nissley; M M Rechler
Journal:  Nature       Date:  1977-06-09       Impact factor: 49.962

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  A human fibrosarcoma cell line producing multiplication stimulating activity (MSA)-related peptides.

Authors:  J E De Larco; G J Tadaro
Journal:  Nature       Date:  1978-03-23       Impact factor: 49.962

6.  Mink cell line Mv 1 Lu (CCL 64). Focus formation and the generation of "nonproducer" transformed cell lines with murine and feline sarcoma viruses.

Authors:  I C Henderson; M M Lieber; G J Todaro
Journal:  Virology       Date:  1974-07       Impact factor: 3.616

7.  Characterization of the binding of multiplication-stimulating activity to a receptor for growth polypeptides in chick embryo fibroblasts.

Authors:  M M Rechler; J M Podskalny; S P Nissley
Journal:  J Biol Chem       Date:  1977-06-10       Impact factor: 5.157

8.  Epithelioid and fibroblastic rat kidney cell clones: epidermal growth factor (EGF) receptors and the effect of mouse sarcoma virus transformation.

Authors:  J E de Larco; G J Todaro
Journal:  J Cell Physiol       Date:  1978-03       Impact factor: 6.384

9.  Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells.

Authors:  G J Todaro; J E De Larco; S Cohen
Journal:  Nature       Date:  1976-11-04       Impact factor: 49.962

10.  Nerve growth factor receptors on human melanoma cells in culture.

Authors:  R N Fabricant; J E De Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

View more
  304 in total

1.  Receptor-based antidote for diphtheria.

Authors:  Jeong-Heon Cha; Joanna S Brooke; Mee Young Chang; Leon Eidels
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

2.  Analysis of the transcriptional program induced by Raf in epithelial cells.

Authors:  A Schulze; K Lehmann; H B Jefferies; M McMahon; J Downward
Journal:  Genes Dev       Date:  2001-04-15       Impact factor: 11.361

3.  Expression of epidermal growth factor and transforming growth factor alpha in interfacial membranes retrieved at revision total hip arthroplasty.

Authors:  J W Xu; J Ma; T F Li; E Waris; A Alberty; S Santavirta; Y T Konttinen
Journal:  Ann Rheum Dis       Date:  2000-10       Impact factor: 19.103

4.  Expression of transforming growth factor alpha in human tissues: immunohistochemical study and northern blot analysis.

Authors:  W Yasui; Z Q Ji; H Kuniyasu; A Ayhan; H Yokozaki; H Ito; E Tahara
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

5.  Recent developments in the structure, function and regulation of platelet-derived growth factor and its receptors.

Authors:  J Tiesman; A Rizzino
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

6.  Transforming growth factor-ßs as modulators of pericellular proteolytic events.

Authors:  J Keski-Oja; J Lohi; M Laiho
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

7.  Normal rat intestinal cells IEC-18: characterization and transfection with immortalizing oncogenes.

Authors:  O Vincentini; C Ciotta; M Bignami; A Stammati; F Zucco
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

Review 8.  The microRNA networks of TGFβ signaling in cancer.

Authors:  V P Sivadas; S Kannan
Journal:  Tumour Biol       Date:  2013-12-10

9.  Induction of vascular endothelial tubular morphogenesis by human glioma cells. A model system for tumor angiogenesis.

Authors:  T Abe; K Okamura; M Ono; K Kohno; T Mori; S Hori; M Kuwano
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

Review 10.  Heterogeneity of human colon carcinoma.

Authors:  M G Brattain; A E Levine; S Chakrabarty; L C Yeoman; J K Willson; B Long
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.